{
  "title": "PPAR agonist",
  "content-preview": "PPAR agonists are drugs which act upon the peroxisome proliferator-activated receptor. They are used for the treatment of symptoms of the metabolic syndrome, mainly for lowering triglycerides and blood sugar.\n\n\n== Classification ==\nPPAR-alpha and PPAR-gamma are the molecular targets of a number of m",
  "url": "https://en.wikipedia.org/wiki/PPAR_agonist",
  "pageid": 18775143,
  "title-terms": {
    "ppar": 1,
    "agonist": 1
  },
  "content-terms": {
    "ppar": 10,
    "agonists": 10,
    "drugs": 4,
    "act": 2,
    "upon": 1,
    "peroxisome": 1,
    "proliferatoractivated": 1,
    "receptor": 1,
    "used": 3,
    "treatment": 3,
    "symptoms": 2,
    "metabolic": 2,
    "syndrome": 2,
    "mainly": 1,
    "lowering": 1,
    "triglycerides": 2,
    "blood": 1,
    "sugar": 1,
    "classification": 1,
    "pparalpha": 3,
    "ppargamma": 2,
    "molecular": 1,
    "targets": 2,
    "number": 2,
    "marketed": 1,
    "main": 4,
    "classes": 1,
    "endogenous": 2,
    "compound": 1,
    "7shydroxydocosahexaenoic": 1,
    "acid": 2,
    "7shdha": 1,
    "docosanoid": 1,
    "derivative": 1,
    "omega3": 1,
    "fatty": 1,
    "dha": 1,
    "isolated": 1,
    "high": 2,
    "affinity": 2,
    "ligand": 1,
    "rat": 1,
    "mouse": 1,
    "brain": 1,
    "7s": 1,
    "enantiomer": 2,
    "bound": 1,
    "micromolar": 1,
    "affity": 1,
    "alpha": 2,
    "10": 1,
    "fold": 1,
    "higher": 1,
    "compared": 1,
    "r": 1,
    "could": 1,
    "trigger": 1,
    "dendritic": 1,
    "activation": 2,
    "ppar\u03b1": 2,
    "target": 3,
    "fibrate": 1,
    "class": 3,
    "amphipathic": 1,
    "carboxylic": 1,
    "acids": 1,
    "clofibrate": 1,
    "gemfibrozil": 1,
    "ciprofibrate": 1,
    "bezafibrate": 1,
    "fenofibrate": 1,
    "originally": 1,
    "indicated": 1,
    "dyslipidemia": 1,
    "cholesterol": 2,
    "recently": 1,
    "disorders": 1,
    "characterized": 1,
    "ppar\u03b3": 2,
    "gamma": 1,
    "drug": 4,
    "thiazolidinediones": 1,
    "tzds": 1,
    "diabetes": 1,
    "mellitus": 1,
    "diseases": 1,
    "feature": 1,
    "insulin": 1,
    "resistance": 1,
    "also": 2,
    "mildly": 1,
    "activated": 1,
    "certain": 1,
    "nsaids": 1,
    "ibuprofen": 1,
    "indoles": 1,
    "well": 2,
    "natural": 1,
    "compounds": 2,
    "known": 1,
    "inhibitors": 1,
    "include": 2,
    "experimental": 2,
    "agent": 1,
    "gw9662": 1,
    "treating": 2,
    "hyperlipidaemia": 1,
    "atherosclerosis": 1,
    "increasing": 1,
    "expression": 1,
    "abca1": 1,
    "transports": 1,
    "extrahepatic": 1,
    "hdl": 1,
    "increased": 1,
    "uptake": 1,
    "excretion": 1,
    "liver": 1,
    "therefore": 2,
    "follows": 1,
    "animal": 3,
    "studies": 1,
    "shown": 2,
    "possible": 1,
    "role": 1,
    "amelioration": 1,
    "pulmonary": 1,
    "inflammation": 1,
    "especially": 1,
    "asthma": 1,
    "ppardelta": 1,
    "ppar\u03b4": 2,
    "delta": 1,
    "research": 6,
    "chemical": 1,
    "named": 1,
    "gw501516": 1,
    "agonism": 1,
    "changes": 1,
    "bodys": 1,
    "fuel": 1,
    "preference": 1,
    "glucose": 1,
    "lipids": 1,
    "dual": 3,
    "pan": 2,
    "fourth": 1,
    "socalled": 1,
    "glitazars": 1,
    "bind": 1,
    "\u03b1": 1,
    "\u03b3": 1,
    "isoforms": 2,
    "currently": 1,
    "active": 1,
    "investigation": 1,
    "larger": 1,
    "subset": 1,
    "aleglitazar": 1,
    "muraglitazar": 1,
    "tesaglitazar": 1,
    "june": 1,
    "2013": 1,
    "saroglitazar": 1,
    "first": 1,
    "glitazar": 1,
    "approved": 1,
    "clinical": 1,
    "use": 1,
    "addition": 1,
    "continuing": 1,
    "development": 2,
    "new": 1,
    "\u03b1\u03b4": 1,
    "\u03b3\u03b4": 1,
    "additional": 1,
    "therapeutic": 1,
    "indications": 1,
    "acting": 1,
    "three": 1,
    "relatively": 1,
    "recent": 1,
    "avenue": 1,
    "depression": 1,
    "addiction": 2,
    "tlr4mediated": 1,
    "nf\u03babmediated": 1,
    "signalling": 1,
    "pathways": 1,
    "implicated": 1,
    "several": 2,
    "opioids": 2,
    "cocaine": 2,
    "appealing": 1,
    "pharmacotherapy": 1,
    "despite": 1,
    "breadth": 1,
    "preclinical": 1,
    "showing": 1,
    "potential": 1,
    "models": 1,
    "addictions": 1,
    "including": 1,
    "alcohol": 1,
    "nicotine": 1,
    "methamphetamine": 1,
    "human": 2,
    "evidence": 2,
    "limited": 1,
    "amount": 1,
    "trials": 1,
    "looking": 1,
    "using": 1,
    "humans": 1,
    "still": 1,
    "low": 1,
    "far": 1,
    "2020": 1,
    "particularly": 1,
    "promising": 1,
    "suggested": 1,
    "hypotheses": 1,
    "poor": 1,
    "translation": 1,
    "potency": 1,
    "selectivity": 1,
    "ligands": 1,
    "sexrelated": 1,
    "variability": 1,
    "species": 1,
    "differences": 1,
    "distribution": 1,
    "signaling": 1,
    "references": 1
  },
  "title-length": 2,
  "content-length": 316,
  "curious_frequency": 10,
  "uplifting_frequency": 0,
  "entertaining_frequency": 0,
  "sad_frequency": 1,
  "general_frequency": 0
}